GSK plc 6-K, filed Jan 8, 2020
GSK plc (GSK)
6-K
2020-01-08
For: 2020-01-08
View Original
Added on
July 04, 2026
About this 6-K
GSK plc filed this 6-K on January 8, 2020.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of January, 2020
Commission
File Number 001-15170
GlaxoSmithKline plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ____
GlaxoSmithKline plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for
2020.
|
|
Results
announcement
date
|
Ex-dividend
date
|
Record date
|
Last date for
DRIP elections
|
Payment date
|
|
Q1 2020
|
Wednesday
29 April
|
Thursday
14 May
|
Friday
15 May
|
Wednesday
17 June
|
Thursday
9 July
|
|
Q2 2020
|
Wednesday
29 July
|
Thursday
13 August
|
Friday
14 August
|
Thursday
17 September
|
Thursday
8 October
|
|
Q3 2020
|
Wednesday
28 October
|
Thursday
12 November
|
Friday
13 November
|
Monday
21 December
|
Thursday
14 January 2021
|
|
Q4 2020
(Final)
|
Wednesday
3 February 2021
|
Thursday
18 February 2021
|
Friday
19 February 2021
|
Tuesday
16 March 2021
|
Thursday
8 April 2021
|
These dates are indicative and may be subject to
change.
Victoria Whyte
Company Secretary
8 January 2020
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GlaxoSmithKline plc
|
|
|
(Registrant)
|
|
|
|
|
Date: January
08, 2020
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GlaxoSmithKline plc
|